Articles

Antiplatelet and Anticoagulation Therapy in ACS

Citation:

US Cardiology Review 2017;11(2):52–8.

Guest Editorial: Commentary on the Findings of the GLAGOV Randomized Clinical Trial

Citation:

US Cardiology Review 2017;11(1):18–9

Guest Editorial: A Brave New World for Non-vitamin K Antagonist Oral Anticoagulants: Have We seen the Last of Warfarin?

Citation:

US Cardiology Review 2017; 11(1):37–8

Foreword

Citation:

US Cardiology Review 2017;11(1):4

Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Inhibition in Patients With or at High Risk of Coronary Heart Disease

Citation:

US Cardiology Review 2017;11(1):16–7

Practical Aspects of Rotor Mapping in Catheter Ablation of Atrial Fibrillation

Citation:

US Cardiology Review 2017;11(1):39–41

When to Use Bioresorbable Vascular Scaffolds

Citation:

US Cardiology Review 2017;11(1):25–30

Cardiac Toxicity of Cancer Chemotherapy

Citation:

US Cardiology Review 2017;11(1):20–4

Dual Anti-platelet Therapy after Coronary Stenting: Rationale for Personalized Duration of Therapy

Citation:

US Cardiology Review 2017;11(1):31–6

Dyslipidemia: Current Therapies and Guidelines for Treatment

Citation:

US Cardiology Review 2017;11(1):10–5